Chrome 2001
.
The Trusted Source InteliHealth Aetna InteliHealth Aetna InteliHealth
Enter Drug Name . Enter Search Term
     
. .
. .
.
Home
Health Commentaries
InteliHealth Dental
Drug Resource Center
Ask the Expert
Interactive Tools
Todays News
InteliHealth Policies
Site Map
Diseases & Conditions Healthy Lifestyle Your Health Look It Up
Mental Health Mental Health E-Mail
.
Associated Press

FDA OKs Prozac For Depressed Children
January 4, 2003

WASHINGTON (AP) -- Prozac is now formally available for depressed children.

Psychiatrists have prescribed the world's best-known antidepressant, and similar competitors, to their youngest patients for years, despite a shortage of studies proving they work in children.

But the Food and Drug Administration declared Friday that there's finally proof that Prozac alleviates depression in children 8 years and older, the first drug among the newer antidepressants, which boost the mood regulator serotonin, to win such approval.

Maker Eli Lilly & Co. said it didn't intend to market Prozac for children. Still, putting child-specific information on Prozac's FDA-mandated label means more doctors, not just depression specialists, may prescribe it.

The FDA also approved Prozac's use in children with obsessive-compulsive disorder, the third serotonin-enhancing drug to win that designation.

Prozac side effects are similar for adults and children, including nausea, tiredness, nervousness, dizziness and difficulty concentrating, the FDA said.

But children have one unique side effect: In one study, children and teenagers taking Prozac grew a little more slowly -- a half inch less in height and 2 pounds less in weight over a period of 19 weeks -- than similarly aged children taking a dummy pill.

No one yet knows if the Prozac patients catch up or how big a concern that is, said the FDA's Dr. Russell Katz. Lilly agreed to further study the side effect.

Up to 25 percent of U.S. children and 8 percent of teenagers suffer depression, the FDA said. Additionally, about 2 percent of the population has obsessive-compulsive disorder, and at least a third of those cases began in childhood.

Psychiatrists welcomed the FDA's move.

"It made sense to prescribe these drugs, but yet everyone who did it felt a certain amount of anxiety that we didn't have all the data," said Dr. Lois Flaherty of the American Psychiatric Association.

Manufacturers have little incentive to study adult drugs in children if they expect desperate pediatricians will use the medicines anyway. In 1998, the FDA tried to require more pediatric testing, but a federal court recently threw out that requirement.

Copyright 2003 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

.
InteliHealth
. . . .
.
More News
InteliHealth .
.
Top News
General Health
This Week In Health
Addiction
Allergy
Alzheimer's
Asthma
Arthritis
Babies
Breast Cancer
Cancer
Caregiving
Cervical Cancer
Children's Health
Cholesterol
Complementary & Alternative Medicine
Dental / Oral Health
Depression
Diabetes
Ear, Nose And Throat
Eyes
Family Health
Fitness
Headache
Heart Health
HIV / AIDS
Infectious Diseases
Lung Cancer
Medications
Men's Health
Mental Health
Nutrition News
Multiple Sclerosis
Nutrition Guide
Parkinson's
Pregnancy
Prevention
Prostate Cancer
Senior Health
Sexual / Reproductive Health
Sleep
Tobacco Cessation
STDs
Stress Reduction
Stroke
Weight Management
Today In Health History
Women's Health
Workplace Health
.
.
.
.
InteliHealth

   
.
.   HONcode
.
Chrome 2001
Chrome 2001